Single ascending dose safety, tolerability, and pharmacokinetic study of econazole in healthy volunteers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Single ascending dose safety, tolerability, and pharmacokinetic study of econazole in healthy volunteers

Published:2022-01-02 Issue: Volume: Page:1-7
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Khera Himanshi¹,Pandey Avaneesh Kumar¹,Shafiq Nusrat¹,Khuller G.K.²,Kondel Bhandari Ritika¹,Panditrao Aditi¹,Gamad Nanda¹,Rohilla Rachna¹,Bhattacharjee Samiksha¹,Murali Naveen¹,cvn Harish¹,Belavagi Devraj¹,Mothsara Chakrant¹,Singh Manjula³,Sharma Navneet⁴,Behera Digamber⁵,Malhotra Samir¹

Affiliation:

1. Department of Pharmacology, Pgimer, Chandigarh, India

2. Department of Biochemistry, PGIMER, Chandigarh, India

3. Division of ECD, Indian Council of Medical Research, New Delhi, India

4. Department of Internal Medicine, Pgimer, Chandigarh, India

5. Department of Pulmonary Medicine, PGIMER, Chandigarh, India

Funder

Therapeutics

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2022.2016392

Reference18 articles.

1. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3

2. World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization; 2013. Licence: CC BY-NC-SA 3.0 IGO.

3. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort

4. India's plan to eliminate tuberculosis by 2025: converting rhetoric into reality

5. Multi-Drug Resistant and Extensively-Drug Resistant Tuberculosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3